Kieran Gallahue - 09 May 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
Director
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
09 May 2025
Net transactions value
$0
Form type
4
Filing time
09 May 2025, 19:57:42 UTC
Previous filing
23 May 2024
Next filing
12 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GALLAHUE KIERAN Director ONE EDWARDS WAY, IRVINE Linda J. Park, Attorney-in-Fact 09 May 2025 0001308428

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Award $0 +3,528 $0.000000 3,528 09 May 2025 Direct F1
transaction EW Common Stock Award $0 +1,154 +33% $0.000000 4,682 09 May 2025 Direct F2
holding EW Common Stock 74,974 09 May 2025 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units were granted on May 9, 2025 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
F2 This restricted stock award was granted on May 9, 2025 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.